MALAT1 and non-small cell lung carcinoma: In vivo and in vitro studies demonstrate that METTL3 enhances the m6A methylation of MALAT1, increasing its transcript stability and upregulating YAP expression through the MALAT1–miR-1914-3p–YAP axis, thereby promoting NSCLC invasion and metastasis (172).